Literature DB >> 3950134

Disseminated extramedullary plasmacytomas.

W A Burke, C C Merritt, R A Briggaman.   

Abstract

A 53-year-old man developed multiple, widespread infiltrative tumors of his lips, eyelids, ears, distal fingers and toes, tongue, buccal mucosa, scrotum, and larynx. Biopsy results of three involved sites were similar, with dermal infiltration by well-differentiated plasma cells. Bone marrow aspirate and biopsy were essentially normal. The patient responded well to therapy with cyclophosphamide, doxorubicin, vincristine, and prednisone. Extramedullary plasmacytoma is a rare disease that most often arises in the upper respiratory tract. The relationship of this entity to other forms of myelomatosis is discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3950134     DOI: 10.1016/s0190-9622(86)70038-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Prognostic factors of laryngeal solitary extramedullary plasmacytoma: a case report and review of literature.

Authors:  Yong Xing; Jun Qiu; Min-Li Zhou; Shui-Hong Zhou; Yang-Yang Bao; Qin-Ying Wang; Zhou-Jun Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Plasmablastic immunoglobulin-secreting lymphoma. Report of a case and a glimpse at the prognosis.

Authors:  G Köchling; A Ochs; G Hauke; R Engelhardt
Journal:  Klin Wochenschr       Date:  1988-10-03

3.  Extramedullary plasmacytoma of the larynx: Literature review and report of a case who subsequently developed acute myeloid leukemia.

Authors:  Shenglei Ge; Ganghua Zhu; Yan Yi
Journal:  Oncol Lett       Date:  2018-06-19       Impact factor: 2.967

4.  Solitary Extramedullary Plasmacytoma of the Larynx and Secondary Laryngeal Involvement in Plasma Cell Myeloma: Single-Centre Retrospective Analysis and Systematic Literature Review.

Authors:  Elżbieta Szczepanek; Joanna Drozd-Sokołowska; Jacek Sokołowski; Anna Rzepakowska; Arkadiusz Moskwa; Jakub Pachla; Jakub Grzybowski; Katarzyna Woźnica; Kazimierz Niemczyk; Krzysztof Jamroziak
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.